Medications

Letermovir noninferior for CMV prophylaxis in kidney recipients

Letermovir is noninferior to valganciclovir for prevention of cytomegalovirus (CMV) among CMV-seronegative kidney transplant recipients who receive an organ from a CMV-seropositive donor, according to a study published online ...

Medications

Merck sues to challenge new US drug price program

Merck filed a lawsuit Tuesday challenging a new White House-backed program to limit drug prices, calling the initiative an unconstitutional "extortion" that will harm pharmaceutical innovation.

page 9 from 40